{"content":[{"text":"information on facebook and other social media with our pages repeatedly being blocked. \n Finally, we believe the lack of clinical experts on the existing task forces is further hindering \n progress on identifying effective therapeutics. We can identify almost no members with any \n similarities to the skill set, clinical knowledge base, and patient care experience to our group of \n expert clinicians. Existing members all seem to be either physician leaders of large health care \n organizations or have research backgrounds. Although many must have had some bedside \n experience in the care of patients in their careers, there seem to be almost none that have been at \n the bedside of COVID- 19 patients in any appreciable fashion during this pandemic. Expert \n clinician panels such as ours have large amounts of valuable insights and wisdom and we are \n extremely pleased to share our recent discovery of the immense potency of Ivermectin in \n COVID-19.","bbox":{"left":0.117647,"top":0.091195,"width":0.7548569999999999,"height":0.191022}},{"text":"Ivermectin is highly safe, widely available, and low cost. Its discovery was awarded the \n Nobel Prize in medicine, and is already included on the WHO’s “World’s List of Essential \n Medicines.” We now have data from over 20 well-designed clinical studies, ten of them \n randomized, controlled trials, with every study consistently reporting large magnitude and \n statistically significant benefits in decreasing transmission rates, shortening recovery times, \n decreasing hospitalizations, or large reductions in deaths. This clinical data is also supported by \n multiple basic science, in-vitro and animal studies. Our manuscript, completed one week ago, is \n already out of date due to the near daily emergence of new, positive ivermectin studies. The \n manuscript has been posted on the medical pre-print server OSF (Open Science Foundation) and \n can be downloaded here https://osf.io/wx3zn/ or on our organization’s website, www.flccc.net. A \n more updated meta-analysis and review authored by a group of Ph.D. researchers and scientists \n includes all ivermectin studies as of December 4th, 2020 and can be found on the c19study.com \n website here: https://ivmmeta.com/","bbox":{"left":0.117647,"top":0.300286,"width":0.76318,"height":0.22586999999999996}},{"text":"These data show that ivermectin is effectively a “miracle drug” against COVID-19. The \n magnitude of the effect is similar to its Nobel prize-worthy historical impacts against parasitic \n disease across many parts of the globe. It should be noted that that Merck, the pharmaceutical \n company whose scientists helped discover ivermectin, has from the first availability of the drug, \n donated hundreds of millions of doses for free to support the WHO parasite eradication \n programs. We believe a similar initiative is needed to eradicate the globe from the scourge of \n COVID-19. Our group held a press conference this past Friday, December 4th at the United \n Memorial Medical Center in Houston, issuing a “Call to Action.” We made a formal request to \n our national and global health care agencies and leaders to rapidly assess the growing scientific \n evidence on ivermectin and update treatment guidelines accordingly. We noted that the last \n treatment recommendation on ivermectin is from August 27th where on the NIH website, they \n recommended that ivermectin only be used in clinical trials and they based that recommendation \n as “expert opinion” only given the lack of clinical studies at the time. There is now a wealth of \n studies reporting efficacy of ivermectin. In that press conference, we called for a rapid and \n updated review of this evidence in the hopes a treatment recommendation could be made and \n thus saving many thousands of lives, quickly. The press conference was broadcast via the \n Associated Press and Univision to nearly every country globally. The Health Ministry of the \n Government of Uganda is currently reviewing our manuscript with the intent of incorporating \n our treatment protocol into a national treatment guideline. It is now 48 hours later and, although \n it has been shared widely, we have not heard from:","bbox":{"left":0.117647,"top":0.544226,"width":0.758507,"height":0.347839}}],"images_bbox":[],"images_bbox_not_text_overlap":[]}